Search This Blog

Wednesday, November 6, 2019

ANI Pharmaceuticals EPS misses by $0.20, misses on revenue

ANI Pharmaceuticals (NASDAQ:ANIP): Q3 Non-GAAP EPS of $1.23 misses by $0.20; GAAP EPS of $0.32 misses by $0.32.
Revenue of $51.34M (+1.3% Y/Y) misses by $4.76M.
Shares +0.33% PM.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)